Showing results (1671-1680 of 8,886) with videos related to

Sort By:
Pageof 889
European Urology|July 8, 2008
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic reviewPatricia Harnden, Michael D Shelley, Brian Naylor, et al.
European Urology|September 29, 2007
Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposalJoop P van de Merwe, Jørgen Nordling, Pierre Bouchelouche, et al.
European Urology|July 31, 2007
PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancerRoman Ganzer, Sebastian Rogenhofer, Bernhard Walter, et al.
European Urology|June 28, 2008
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate sizeClaus G Roehrborn, Steven A Kaplan, J Stephen Jones, et al.
European Urology|July 1, 2008
Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination projectMargot Wink, Ferdinand Frauscher, David Cosgrove, et al.
European Urology|July 1, 2008
Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapyDominique Helley, Eugeniu Banu, Abdelkader Bouziane, et al.
European Urology|July 1, 2008
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsAmit Gupta, Yair Lotan, Raheela Ashfaq, et al.
European Urology|July 1, 2008
Prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a reviewRoderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, et al.
European Urology|November 17, 2007
Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancerLynn N Thomas, Robert C Douglas, Catherine B Lazier, et al.
European Urology|November 18, 2008
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT studyClaus G Roehrborn, Paul Siami, Jack Barkin, et al.
Pageof 889